Pharmaceuticals Trio Draw Buy Ratings Ahead of 2026 Catalysts
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Flexible budgets empower you to adjust spending as circumstances shift, strengthening your overall planning and helping you stay on track toward financial goals.
21,409 articlesA trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Investing in small biotech stocks offers the potential for outsized gains — but only with a clear process. This guide...
Minnesota’s business elite issued a restrained message on immigration enforcement that drew sharp critique and raised...
A major fund just boosted its stake in a struggling auto-parts retailer. This article breaks down what the move could...
Energy Transfer sits at the heart of U.S. energy infrastructure. This guide explains when energy transfer stock right...
Oil stocks are soaring, yet chasing momentum can backfire. This guide outlines three practical here considerations yo...
Powell confirms he will remain as chair pro tem if Warsh is not confirmed by mid-May, delivering a clear answer amid ...
A rising fintech stock year story shows profits climbing while a major fund trims nearly $300M from its stake. The mo...
A federal jury in San Francisco ruled that Elon Musk misled Twitter investors ahead of the 2022 buyout, setting up a ...
Alibaba.com's leader previews a future where a single founder can run a global B2B business with AI handling the heav...
Warren Buffett built wealth by buying durable businesses at fair prices. In this guide, we explore a Buffett-inspired...
A quiet revolution in AI compute centers around CPUs designed for AI workloads. This article explains why the era of ...